secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lifeward Ltd. (LFWD)
CIK:        0001607962
Form:       8-K
Filed at:   2023-02-23T23:59:59+00:00
Accession:  0001178913-23-000720
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ReWalk Q4 revenue $2.2M (+75% YoY); full-year net loss $19.6M; cash $67.9M no debt
--------------------------------------------------------------------------------

- Q4 2022 revenue $2.2M, up 75% from $1.2M in Q4 2021; full-year revenue $5.5M vs $6.0M in 2021.
- Q4 net loss $5.3M ($3.9M in Q4 2021); full-year net loss $19.6M ($12.7M in 2021).
- Cash and equivalents $67.9M as of Dec 31, 2022, with no debt.
- Submitted first exoskeleton claim for Medicare coverage via MACs in Q4; preparing for expanded patient access.
- Repurchased $3.3M of ordinary shares since Q3 2022; record quarterly MyoCycle sales.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1607962/000117891323000720/0001178913-23-000720-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1607962/000117891323000720/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001178913-23-000720

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer